Molecular breast imaging. Seeing past dense breast tissue
Mayo Clinic Health Letter 30(2): 7
2012
ISSN/ISBN: 0741-6245 PMID: 27024368 Document Number: 661944
Document emailed within 1 workday
Related Documents
Schultz, D.C.; Bazel, S.; Wright, L.M.; Tucker, S.; Lange, M.K.; Tachovsky, T.; Longo, S.; Niedbala, S.; Alhadeff, J.A. 1994: Western blotting and enzymatic activity analysis of cathepsin D in breast tissue and sera of patients with breast cancer and benign breast disease and of normal controls Cancer Research 54(1): 48-54Shi, J.; Wang, R.; Zhou, S.; Chang, C. 2010: The research progress of breast ultrasound CAD with breast imaging and reporting data system Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 27(5): 1169-1172
Trecate, G.; Tess, J.D.; Vergnaghi, D.; Bergonzi, S.; Mariani, G.; Ferraris, C.; Musumeci, R. 2001: Lobular breast cancer: how useful is breast magnetic resonance imaging? Tumori 87(4): 232-238
Puchkova, O.S.; Sinitsyn, V.E.; Mershina, E.A. 2016: The Role of Preoperative Breast Magnetic Resonance Imaging in Planning of Optimum Surgical Treatment for Breast Cancer Patients Vestnik Rentgenologii i Radiologii 97(6): 373-381
Menes, T.S.; Zissman, S.; Golan, O.; Sperber, F.; Klausner, J.; Schneebaum, S. 2012: Yield of selective magnetic resonance imaging in preoperative workup of newly diagnosed breast cancer patients planned for breast conserving surgery American Surgeon 78(4): 451-455
Pavelic, Z.P.; Pavelic, L.; Lower, E.E.; Gapany, M.; Gapany, S.; Barker, E.A.; Preisler, H.D. 1992: C-myc, c-erbB-2, and Ki-67 expression in normal breast tissue and in invasive and noninvasive breast carcinoma Cancer Research 52(9): 2597-2602
Zhu, Z.R.; Parviainen, M.; Männistö, S.; Pietinen, P.; Eskelinen, M.; Syrjänen, K.; Uusitupa, M. 1995: Vitamin a concentration in breast adipose tissue of breast cancer patients Anticancer Research 15(4): 1593-1596
Saleh, H.A.; Klein, L.H. 1990: Cystosarcoma phyllodes arising synchronously in right breast and bilateral axillary ectopic breast tissue Archives of Pathology and Laboratory Medicine 114(6): 624-626
Friedrich, M.; Villena-Heinsen, C.; He, J.; Mink, D.; Reichrath, J.; Reitnauer, K.; Schmidt, W. 1998: Correlation between immunoreactivity for transglutaminase K and for markers of proliferation and differentiation in normal breast tissue and breast carcinomas European Journal of Gynaecological Oncology 19(5): 444-448
Williams, C.M.; Maunder, K. 1993: Fatty acid compositions of inositol and choline phospholipids of breast tumours and normal breast tissue European Journal of Clinical Nutrition 47(4): 260-267
Kizawa, R.; Ozaki, Y.; Kondoh, C.; Tanabe, Y.; Takano, T. 2017: I. Dose-Dense Chemotherapy as Perioperative Treatment in Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 44(13): 2073-2076
Albeshan, S.M.; Hossain, S.Z.; Mackey, M.G.; Brennan, P.C. 2020: Can Breast Self-examination and Clinical Breast Examination Along with Increasing Breast Awareness Facilitate Earlier Detection of Breast Cancer in Populations with Advanced Stages at Diagnosis? Clinical Breast Cancer 20(3): 194-200
Leonard, J.P. 2003: Improved outcomes from dose-dense adjuvant chemotherapy for breast cancer with growth factor support Current Hematology Reports 2(6): 451-452
Al-Boukai, A.A. 2010: Bilateral intraductal papillomas arising in ectopic axillary breast tissue synchronously with right breast intraductal carcinoma Saudi Medical Journal 31(3): 321-324
Seidman, A.D.; Hudis, C.A.; McCaffrey, J.; Tong, W.; Currie, V.; Moynahan, M.E.; Theodoulou, M.; Tepler, I.; Gollub, M.; Norton, L. 1997: Dose-dense therapy with paclitaxel via weekly 1-hour infusion: preliminary experience in the treatment of metastatic breast cancer Seminars in Oncology 24(5 Suppl 17: S17
Derebek, E.; Balci, P.; Alanyali, H.; Kocdor, M.A.; Capa, G.; Gorken, I.B.; Degirmenci, B.; Alakavuklar, M.; Canda, T.; Durak, H. 1999: Detection of bilateral multifocal breast cancer using Tc-99m sestamibi imaging. The role of delayed imaging Clinical Nuclear Medicine 24(8): 590-593
Burtness, B.; Windsor, S.; Holston, B.; DiStasio, S.; Staugaard-Hahn, C.; Abrantes, J.; Kneuper-Hall, R.; Farber, L.; Orell, J.; Bober-Sorcinelli, K.; Haffty, B.G.; Reiss, M. 1999: Adjuvant sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide (ATC) for high-risk breast cancer is feasible in the community setting Cancer Journal From Scientific American 5(4): 224-229
Melichar, B.; Urbánek, L.; Krcmová, L.; Kalábová, H.; Melicharová, K.; Malírová, E.; Hornychová, H.; Ryska, A.; Hyspler, R.ír.; Solichová, D. 2008: Urinary neopterin, hemoglobin and peripheral blood cell counts in breast carcinoma patients treated with dose-dense chemotherapy Anticancer Research 28(4c): 2389-2396
Petrakis, N.L. 1977: Breast secretory activity in nonlactating women, postpartum breast involution, and the epidemiology of breast cancer National Cancer Institute Monograph 47: 161-164
Hooning, M.J.; van Dongen, J.A.; Went, G. 1991: Changing indications for breast conserving therapy: proportion of patients with operable breast cancer suitable for breast conservation Netherlands Journal of Surgery 43(4): 102-104